Tag Archive for: bone and soft tissue

Biocomposites announces two new Phase II clinical trials of STIMULAN VG – a calcium matrix antibiotic carrier mixed with vancomycin and gentamicin – in the U.S.

/in

BLADE-VG2 trial will evaluate the safety and efficacy of STIMULAN VG to treat diabetic foot osteomyelitis BLADE-OPU2 will evaluate the safety and efficacy of STIMULAN VG to treat stage IV pressure ulcers Keele, UK, 7 February 2024 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management […]

Read more

Biocomposites announce a year of record sales and company growth

/in

Winner of two Queen’s Awards for Enterprise in Innovation and International Trade Highest year-on-year sales growth in the company’s 25-year history Keele, UK, 14 December 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is celebrating its 25th anniversary […]

Read more

Biocomposites adds Mexico to its list of countries where STIMULAN is approved as an antibiotic carrier for use in bone and soft tissue

/in

STIMULAN® gives surgeons the freedom to choose and combine the antibiotics that support their infection treatment strategy Keele, UK, 29 November 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to announce that STIMULAN® has received a new […]

Read more

Biocomposites appoints Group Chief Financial Officer and New UK General Manager

/in

Keele, UK, 15 June 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is pleased to announce two new appointments. Simon Greenhalgh has been appointed Group Chief Financial Officer (CFO) and Pete Webster takes up the position of UK […]

Read more

Biocomposites to present data on STIMULAN® and genex® at ECCMID 2022

/in

Research findings from two studies demonstrate the antimicrobial effectiveness of STIMULAN® and genex®, when mixed with antibiotics Keele, UK, 12 April 2022,– Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces the acceptance of two posters at the 32nd European […]

Read more